|Application ||WB, IHC-P, E|
|Other Accession||Q0VBP7, NP_001092764.1|
|Antigen Region||18-46 aa|
|Other Names||Uncharacterized protein KIAA1644, KIAA1644|
|Target/Specificity||This KIAA1644 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 18-46 amino acids from the N-terminal region of human KIAA1644.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||KIAA1644 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Membrane; Single-pass type I membrane protein EMBL; AL022339; CAI41964.2; -; Genomic_DNA EMBL; AL591914; CAI41964.2; JOINED; Genomic_DNA EMBL; AL591914; CAM28349.1; -; Genomic_DNA EMBL; AL022339; CAM28349.1; JOINED; Genomic_DNA EMBL; BC104183; AAI04184.1; -; mRNA EMBL; BC104184; AAI04185.1; -; mRNA EMBL; AB051431; BAB33314.1; -; mRNA CCDS; CCDS43025.1; - RefSeq; NP_001092764.1; NM_001099294.1 RefSeq; XP_005261847.1; XM_005261790.3 UniGene; Hs.6829; - ProteinModelPortal; Q3SXP7; - STRING; 9606.ENSP00000370568; - BioMuta; KIAA1644; - DMDM; 172044643; - PaxDb; Q3SXP7; - PRIDE; Q3SXP7; - Ensembl; ENST00000381176; ENSP00000370568; ENSG00000138944 GeneID; 85352; - KEGG; hsa:85352; - UCSC; uc003bet.3; human CTD; 85352; - DisGeNET; 85352; - GeneCards; KIAA1644; - HGNC; HGNC:29335; KIAA1644 HPA; HPA051178; - neXtProt; NX_Q3SXP7; - OpenTargets; ENSG00000138944; - PharmGKB; PA164721896; - eggNOG; ENOG410IJIJ; Eukaryota eggNOG; ENOG410Y76U; LUCA GeneTree; ENSGT00390000006791; - HOGENOM; HOG000170254; - HOVERGEN; HBG108041; - InParanoid; Q3SXP7; - OMA; HYRVCEP; - OrthoDB; EOG091G0NP0; - PhylomeDB; Q3SXP7; - TreeFam; TF331539; - GenomeRNAi; 85352; - PRO; PR:Q3SXP7; - Proteomes; UP000005640; Chromosome 22 Bgee; ENSG00000138944; - Genevisible; Q3SXP7; HS GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW 2: Evidence at transcript level; Complete proteome; Glycoprotein; Membrane; Reference proteome; Signal; Transmembrane; Transmembrane helix SIGNAL 1 25 CHAIN 26 199 Uncharacterized protein KIAA1644 /FTId=PRO_0000318951 TOPO_DOM 26 97 Extracellular. TRANSMEM 98 118 Helical. TOPO_DOM 119 199 Cytoplasmic. CARBOHYD 53 53 N-linked (GlcNAc...). CARBOHYD 95 95 N-linked (GlcNAc...). CONFLICT 197 197 S -> L (in Ref. 2; AAI04185) SEQUENCE 199 AA; 22573 MW; 55C8E5B55D3B60F6 CRC64; MTSCGQQSLN VLAVLFSLLF SAVLSAHFRV CEPYTDHKGR YHFGFHCPRL SDNKTFILCC HHNNTVFKYC CNETEFQAVM QANLTASSEG YMHNNYTALL GVWIYGFFVL MLLVLDLLYY SAMNYDICKV YLARWGIQGR WMKQDPRRWG NPARAPRPGQ RAPQPQPPPG PLPQAPQAVH TLRGDAHSPP LMTFQSSSA|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Hirosawa, M., et al. DNA Res. 8(1):1-9(2001)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.